Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-negative chronic hepatitis B (CHB)
Titel:
Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-negative chronic hepatitis B (CHB)
Auteur:
Rizzetto, M. Marcellin, P. Andreone, P. Buti, M. Krastev, Z. Germanidis, G. Kaita, K. Kotzev, I. Buggisch, P. Weilert, F. Sorbel, J. Anderson, J. Mondou, E. Rousseau, F.